Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373786

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373786

Global Cell Lysis Market Size, Share, Growth Analysis, By Type(Mechanical disruption, enzymatic lysis) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Cell Lysis Market size was valued at USD 2.9 billion in 2021 and is poised to grow from USD 3.11 billion in 2022 to USD 5.42 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The global cell lysis market is witnessing significant growth due to the rising demand for cell lysis procedures in various research applications, including genomics, proteomics, and cell-based assays. Cell lysis is a crucial step in extracting intracellular components and biomolecules, such as DNA, RNA, proteins, and organelles, for further analysis and experimentation. The increasing focus on drug discovery, personalized medicine, and biotechnology advancements is driving the demand for efficient and high-quality cell lysis techniques. Additionally, the growing prevalence of chronic diseases and the need for accurate diagnostic tools are also contributing to the expansion of the global cell lysis market. With technological innovations and automation in cell lysis procedures, the market is poised for continued growth in the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Cell Lysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Lysis Market Segmental Analysis

The global cell lysis market is segmented by type and region. Based on type, the market can be segmented into mechanical disruption, enzymatic lysis, freeze-thaw cycles, and chemical lysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Cell Lysis Market

Increasing Demand For Cell-Based Research And Development Activities

  • One driver of the global cell lysis market is the increasing demand for cell-based research and development activities in various fields such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis is an essential step in extracting cellular components for further analysis and experimentation. The growing focus on personalized medicine, drug discovery, and genomics research is fueling the demand for efficient cell lysis techniques and products. Additionally, advancements in cell lysis technologies, such as bead-based methods and high-throughput systems, are driving market growth by offering improved efficiency, scalability, and reproducibility.

Restraints in the Global Cell Lysis Market

High Cost Associated With Cell Lysis Products And Equipment

  • One restraint of the global cell lysis market is the high cost associated with cell lysis products and equipment. Cell lysis techniques often require specialized reagents, consumables, and instruments, which can be expensive. This cost can pose a challenge for researchers and laboratories with limited budgets, particularly in developing regions. Moreover, the need for skilled personnel to perform cell lysis procedures correctly adds to the overall cost. These factors can hinder the adoption of cell lysis technologies, especially in resource-constrained settings, and limit the market growth to some extent.

Market Trends of Global Cell Lysis Key

  • One key market trend in the global cell lysis market is the growing demand for automated and high-throughput cell lysis systems. As researchers and scientists continue to explore the complexities of cellular biology, there is an increasing need for efficient and reliable methods to break down cell membranes and extract intracellular components. Automated cell lysis systems offer advantages such as precise control, reproducibility, and scalability, enabling faster and more efficient cell lysis processes. Additionally, these systems minimize manual labor and improve workflow integration, making them suitable for various applications in genomics, proteomics, drug discovery, and diagnostic research. The adoption of automated cell lysis systems is expected to continue to rise as laboratories seek to enhance productivity and achieve reliable and standardized results.
Product Code: SQMIG35G2165

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Cell Lysis Market by Type
    • Market Overview
    • Mechanical disruption
    • enzymatic lysis
    • freeze-thaw cycles
    • and chemical lysis
  • Global Cell Lysis Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • BioLysis Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CellBurst Technologies Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lysate Solutions GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CytoLysis Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CellFree Labs Ltd. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BioLysis Japan Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LysisGenetics S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CellLysis Systems Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lysate Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CytoRelease Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BioLysis Australia Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CellBurst Innovations Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lysate Solutions Asia Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CytoLysis Biomedical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CellFree Technologies Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BioLysis Nordic AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LysisGen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CellLysis Solutions Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LysateTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CytoRelease Japan Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!